
Boehringer has revealed that it intends to withdraw its investment from Hikma Pharmaceuticals, with the company poised to sell 28 …

Hikma Pharmaceuticals has announced that Surendera Tyagi is being brought in to join the company as Group Chief Scientific Officer …

It wasn’t so long ago that pharmaceutical companies could change the prices of its products with little scrutiny. A series …

Hikma has completed its acquisition of assets of the US generic injectables business Bedford Laboratories from Ben Venue Laboratories, a …

Jordanian drugmaker Hikma has signed a strategic-level deal with Unilife for the manufacture of generic injectable drugs using its pre-filled …

UK-headquartered Hikma Pharmaceuticals has signed a flurry of deals that expand its position in the fast-growing Middle East and North …

